NBOCA Outlier Reporting 2023 onwards
Risk-adjusted 2-year mortality will be outlier reported in 2023. From 2024, outlier reporting will resume for all of the NBOCA trust/MDT outcomes.
Data Entry 2023 and Onwards
NBOCA has moved into the National Cancer Audit Collaborating Centre and the Royal College of Surgeons of England. Future reporting will use existing national datasets.
New NBOCA open access paper – variation in outcomes following systemic therapy delivery
NBOCA have published a new paper looking at variation in outcomes following systemic anti-cancer therapy (SACT) delivery.
New NBOCA paper published looking at the impact of dementia and colorectal cancer survival
NBOCA have published a new paper looking at colorectal cancer survival and dementia.
NBOCA work on bowel cancer in patients with inflammatory bowel disease published
NBOCA has published a paper on outcomes in patients with colorectal cancer and inflammatory bowel disease.
NBOCA short report on rectal surgery volume published
New short report aiming to improve the accuracy and robustness of the methodology used to measure rectal surgery volume, as well as exploring patient, institution, and surgeon-level characteristics according to rectal surgery volumes.
NBOCA work on survival rates by completion of chemotherapy published
NBOCA has published a paper on the impact of completion of adjuvant chemotherapy for stage III colon cancer on 3-year cancer-specific mortality.
**Announcement of new NBOCA surgical co-lead**
We are pleased to announce that Nicola Fearnhead has been appointed as the new Surgical Co-Lead for the National Bowel Cancer Audit. After six years of commitment to the audit, Jim Hill is now stepping down and we thank him for all of his hard work over this time.